J Neurochem. 2005 Jul;94(2):352-9.

A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.

Source

Department of Pharmacology, The Ohio State University College of Medicine, Columbus, Ohio, USA.

Abstract

Previously, we reported that Phe105 in transmembrane domain 2 of the mouse dopamine transporter (DAT) is crucial for high-affinity cocaine binding. In the current study, we investigated whether other residues surrounding Phe105 also affect the potency of cocaine inhibition. After three rounds of sequential random mutagenesis at these residues, we found a triple mutant (L104V, F105C and A109V) of mouse DAT that retained over 50% uptake activity and was 69-fold less sensitive to cocaine inhibition when compared with the wild-type mouse DAT. The triple mutation also resulted in a 47-fold decrease in sensitivity to methylphenidate inhibition, suggesting that the binding sites for cocaine and methylphenidate may overlap. In contrast, the inhibition of dopamine uptake by amphetamine or methamphetamine was not significantly changed by the mutations, suggesting that the binding sites for the amphetamines differ from those for cocaine and methylphenidate. Such functional but cocaine-insensitive DAT mutants can be used to generate a knock-in mouse line to study the role of DAT in cocaine addiction.

PMID:: 15998286; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

DA014610/DA/NIDA NIH HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. [J Pharmacol Exp Ther. 2005]
Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kozikowski AP, Pan S, Surratt CK. J Pharmacol Exp Ther. 2005 Aug; 314(2):575-83. Epub 2005 May 5.
Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition. [Mol Pharmacol. 1999]
Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
Lin Z, Wang W, Kopajtic T, Revay RS, Uhl GR. Mol Pharmacol. 1999 Aug; 56(2):434-47.
Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains. [Mol Pharmacol. 2000]
Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
Lin Z, Wang W, Uhl GR. Mol Pharmacol. 2000 Dec; 58(6):1581-92.
Review The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate. [Prog Drug Res. 2002]
Review The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate.
Schenk JO. Prog Drug Res. 2002; 59:111-31.
Review The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions. [Eur J Pharmacol. 2003]
Review The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions.
Uhl GR, Lin Z. Eur J Pharmacol. 2003 Oct 31; 479(1-3):71-82.

See reviews... See all...

Cited by 12 PubMed Central articles

A catecholamine transporter from the human parasite Schistosoma mansoni with low affinity for psychostimulants. [Mol Biochem Parasitol. 2011]
A catecholamine transporter from the human parasite Schistosoma mansoni with low affinity for psychostimulants.
Larsen MB, Fontana AC, Magalhães LG, Rodrigues V, Mortensen OV. Mol Biochem Parasitol. 2011 May; 177(1):35-41. Epub 2011 Jan 18.
Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration. [Biol Psychiatry. 2011]
Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration.
Ferris MJ, Mateo Y, Roberts DC, Jones SR. Biol Psychiatry. 2011 Feb 1; 69(3):201-7.
Potencies of cocaine methiodide on major cocaine targets in mice. [PLoS One. 2009]
Potencies of cocaine methiodide on major cocaine targets in mice.
Hill ER, Tian J, Tilley MR, Zhu MX, Gu HH. PLoS One. 2009 Oct 26; 4(10):e7578. Epub 2009 Oct 26.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
OMIM (calculated)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as references in the light bulb links within or in the citations at the end of the OMIM record. The references available through the light bulb link are collected using the PubMed related articles algorithm to identify records with similar terminology to the OMIM record.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

A triple mutation in the second transmembrane domain of mouse dopamine transport...
A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
J Neurochem. 2005 Jul ;94(2):352-9.

PubMed
Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 ago...
Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures.
J Neurochem. 2005 Jul ;94(2):289-98.

PubMed
Similar medication compliance and control of dyslipidemia with simvastatin or at...
Similar medication compliance and control of dyslipidemia with simvastatin or atorvastatin in a staff-model HMO medical clinic.
J Manag Care Pharm. 2005 Jul-Aug ;11(6):499-504.

PubMed
Treatment of gout and crystal arthropathies and uses and mechanisms of action of...
Treatment of gout and crystal arthropathies and uses and mechanisms of action of nonsteroidal anti-inflammatory drugs.
Curr Opin Rheumatol. 1992 Jun ;4(3):295-300.

PubMed
Synthesis and characterization of diverse coordination polymers. Linear and zigz...
Synthesis and characterization of diverse coordination polymers. Linear and zigzag chains involving their structural transformation via intermolecular hydrogen-bonded, interpenetrating ladders polycatenane, and noninterpenetrating square grid from long, rigid N,N'-bidentate ligands: 1,4-bis[(x-pyridyl)ethynyl]benzene (x = 3 and 4).
Inorg Chem. 2005 Jul 11 ;44(14):5047-59.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: